nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inhibitors—Cyclosporine—focal segmental glomerulosclerosis	0.776	1	CiPCiCtD
Aprepitant—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0436	0.241	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0436	0.241	CbGbCtD
Aprepitant—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0327	0.181	CbGbCtD
Aprepitant—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0264	0.146	CbGbCtD
Aprepitant—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.121	CbGbCtD
Aprepitant—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0705	CbGbCtD
Aprepitant—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0351	CcSEcCtD
Aprepitant—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.0266	CcSEcCtD
Aprepitant—TACR3—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.000777	0.0584	CbGpPWpGaD
Aprepitant—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.0263	CcSEcCtD
Aprepitant—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.0242	CcSEcCtD
Aprepitant—TACR3—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.000597	0.0449	CbGpPWpGaD
Aprepitant—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00058	0.0198	CcSEcCtD
Aprepitant—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000539	0.0184	CcSEcCtD
Aprepitant—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.0176	CcSEcCtD
Aprepitant—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.0162	CcSEcCtD
Aprepitant—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.000466	0.0159	CcSEcCtD
Aprepitant—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.0155	CcSEcCtD
Aprepitant—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000447	0.0153	CcSEcCtD
Aprepitant—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.0146	CcSEcCtD
Aprepitant—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.0146	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000423	0.0318	CbGpPWpGaD
Aprepitant—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.0135	CcSEcCtD
Aprepitant—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.0134	CcSEcCtD
Aprepitant—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000384	0.0131	CcSEcCtD
Aprepitant—TACR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.000379	0.0285	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.000372	0.028	CbGpPWpGaD
Aprepitant—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000368	0.0126	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000365	0.0275	CbGpPWpGaD
Aprepitant—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.0125	CcSEcCtD
Aprepitant—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.0124	CcSEcCtD
Aprepitant—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.012	CcSEcCtD
Aprepitant—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000344	0.0118	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000333	0.025	CbGpPWpGaD
Aprepitant—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000322	0.011	CcSEcCtD
Aprepitant—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.0107	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000311	0.0234	CbGpPWpGaD
Aprepitant—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.0106	CcSEcCtD
Aprepitant—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.0106	CcSEcCtD
Aprepitant—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000304	0.0104	CcSEcCtD
Aprepitant—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.0104	CcSEcCtD
Aprepitant—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000299	0.0102	CcSEcCtD
Aprepitant—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.0102	CcSEcCtD
Aprepitant—TACR1—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.000292	0.0219	CbGpPWpGaD
Aprepitant—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.0099	CcSEcCtD
Aprepitant—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00974	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000285	0.0214	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000281	0.0211	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000278	0.0209	CbGpPWpGaD
Aprepitant—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.0095	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00944	CcSEcCtD
Aprepitant—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00939	CcSEcCtD
Aprepitant—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00925	CcSEcCtD
Aprepitant—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.00919	CcSEcCtD
Aprepitant—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000268	0.00917	CcSEcCtD
Aprepitant—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00911	CcSEcCtD
Aprepitant—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000265	0.00906	CcSEcCtD
Aprepitant—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000265	0.00906	CcSEcCtD
Aprepitant—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.00893	CcSEcCtD
Aprepitant—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.00891	CcSEcCtD
Aprepitant—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00888	CcSEcCtD
Aprepitant—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00888	CcSEcCtD
Aprepitant—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00883	CcSEcCtD
Aprepitant—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00881	CcSEcCtD
Aprepitant—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00881	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000255	0.0191	CbGpPWpGaD
Aprepitant—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00864	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000245	0.0184	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000241	0.0181	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000238	0.0179	CbGpPWpGaD
Aprepitant—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.00809	CcSEcCtD
Aprepitant—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00807	CcSEcCtD
Aprepitant—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00803	CcSEcCtD
Aprepitant—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.00799	CcSEcCtD
Aprepitant—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000233	0.00797	CcSEcCtD
Aprepitant—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.00758	CcSEcCtD
Aprepitant—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00755	CcSEcCtD
Aprepitant—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00738	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000216	0.0162	CbGpPWpGaD
Aprepitant—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.00733	CcSEcCtD
Aprepitant—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000213	0.0073	CcSEcCtD
Aprepitant—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00719	CcSEcCtD
Aprepitant—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000208	0.00713	CcSEcCtD
Aprepitant—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00708	CcSEcCtD
Aprepitant—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00698	CcSEcCtD
Aprepitant—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000203	0.00693	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.0002	0.0151	CbGpPWpGaD
Aprepitant—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00681	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000198	0.0149	CbGpPWpGaD
Aprepitant—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00663	CcSEcCtD
Aprepitant—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00657	CcSEcCtD
Aprepitant—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00654	CcSEcCtD
Aprepitant—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00647	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000188	0.0142	CbGpPWpGaD
Aprepitant—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00638	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000187	0.014	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.000182	0.0137	CbGpPWpGaD
Aprepitant—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.00618	CcSEcCtD
Aprepitant—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00613	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000179	0.0135	CbGpPWpGaD
Aprepitant—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00611	CcSEcCtD
Aprepitant—TACR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000178	0.0134	CbGpPWpGaD
Aprepitant—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00603	CcSEcCtD
Aprepitant—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00603	CcSEcCtD
Aprepitant—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00603	CcSEcCtD
Aprepitant—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00601	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00599	CcSEcCtD
Aprepitant—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00596	CcSEcCtD
Aprepitant—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000172	0.00589	CcSEcCtD
Aprepitant—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00583	CcSEcCtD
Aprepitant—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00578	CcSEcCtD
Aprepitant—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00578	CcSEcCtD
Aprepitant—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00574	CcSEcCtD
Aprepitant—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00567	CcSEcCtD
Aprepitant—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00566	CcSEcCtD
Aprepitant—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000164	0.00561	CcSEcCtD
Aprepitant—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00559	CcSEcCtD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000163	0.0122	CbGpPWpGaD
Aprepitant—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000161	0.00551	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00016	0.012	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000154	0.00526	CcSEcCtD
Aprepitant—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00523	CcSEcCtD
Aprepitant—TACR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000152	0.0114	CbGpPWpGaD
Aprepitant—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00519	CcSEcCtD
Aprepitant—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.00515	CcSEcCtD
Aprepitant—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00514	CcSEcCtD
Aprepitant—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000149	0.00509	CcSEcCtD
Aprepitant—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00502	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00499	CcSEcCtD
Aprepitant—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00498	CcSEcCtD
Aprepitant—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00494	CcSEcCtD
Aprepitant—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00494	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000144	0.0108	CbGpPWpGaD
Aprepitant—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00476	CcSEcCtD
Aprepitant—TACR1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000139	0.0104	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00472	CcSEcCtD
Aprepitant—TACR1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000137	0.0103	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000136	0.0102	CbGpPWpGaD
Aprepitant—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00459	CcSEcCtD
Aprepitant—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00457	CcSEcCtD
Aprepitant—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00457	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000133	0.00997	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000129	0.0097	CbGpPWpGaD
Aprepitant—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000125	0.00426	CcSEcCtD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000124	0.00934	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000122	0.00915	CbGpPWpGaD
Aprepitant—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.00415	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00012	0.009	CbGpPWpGaD
Aprepitant—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00012	0.00409	CcSEcCtD
Aprepitant—TACR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000118	0.00886	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000116	0.00874	CbGpPWpGaD
Aprepitant—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.00395	CcSEcCtD
Aprepitant—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.00382	CcSEcCtD
Aprepitant—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00367	CcSEcCtD
Aprepitant—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00364	CcSEcCtD
Aprepitant—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00364	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000106	0.00797	CbGpPWpGaD
Aprepitant—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00362	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000105	0.00793	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000105	0.00792	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000105	0.00789	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000101	0.00759	CbGpPWpGaD
Aprepitant—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0001	0.00343	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.97e-05	0.00749	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	9.78e-05	0.00735	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	9.66e-05	0.00726	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	9.63e-05	0.00724	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	9.58e-05	0.0072	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	9.2e-05	0.00692	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	9.16e-05	0.00688	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	9.11e-05	0.00685	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	8.87e-05	0.00667	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	8.75e-05	0.00657	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	8.32e-05	0.00626	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	8.18e-05	0.00615	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	8.11e-05	0.0061	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.05e-05	0.00605	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	7.8e-05	0.00587	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.74e-05	0.00582	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	7.36e-05	0.00554	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.01e-05	0.00527	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.88e-05	0.00517	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	6.86e-05	0.00516	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	6.48e-05	0.00487	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.24e-05	0.00469	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	5.94e-05	0.00447	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.71e-05	0.00429	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.69e-05	0.00428	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.66e-05	0.00425	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	5.49e-05	0.00412	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.18e-05	0.0039	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.18e-05	0.00389	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.15e-05	0.00387	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	4.93e-05	0.00371	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	4.87e-05	0.00366	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.76e-05	0.00358	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.7e-05	0.00354	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.68e-05	0.00352	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.47e-05	0.00336	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.35e-05	0.00327	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.33e-05	0.00326	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.96e-05	0.00298	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.93e-05	0.00296	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.78e-05	0.00284	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.69e-05	0.00277	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.6e-05	0.0027	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.58e-05	0.00269	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.39e-05	0.00255	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.36e-05	0.00252	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.06e-05	0.0023	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.05e-05	0.00229	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.83e-05	0.00213	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.79e-05	0.0021	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.78e-05	0.00209	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.76e-05	0.00208	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.53e-05	0.0019	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.35e-05	0.00177	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.32e-05	0.00175	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	2.28e-05	0.00171	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.12e-05	0.0016	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.8e-05	0.00136	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.8e-05	0.00135	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.75e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.66e-05	0.00124	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.54e-05	0.00116	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.5e-05	0.00112	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.49e-05	0.00112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.41e-05	0.00106	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.38e-05	0.00104	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.36e-05	0.00102	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.24e-05	0.000931	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.23e-05	0.000924	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.2e-05	0.000904	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.15e-05	0.000864	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.08e-05	0.000814	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.06e-05	0.000796	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.97e-06	0.00075	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.42e-06	0.000708	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	8.89e-06	0.000668	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.81e-06	0.000662	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	8.59e-06	0.000645	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.06e-06	0.000605	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	7.83e-06	0.000588	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	7.5e-06	0.000564	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.34e-06	0.000552	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.34e-06	0.000551	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.26e-06	0.000546	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.21e-06	0.000542	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	6.87e-06	0.000517	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	6.42e-06	0.000483	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.28e-06	0.000472	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	6.27e-06	0.000471	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.18e-06	0.000465	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	6.05e-06	0.000455	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.64e-06	0.000424	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.57e-06	0.000419	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	5.52e-06	0.000415	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	5.42e-06	0.000408	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.35e-06	0.000402	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.08e-06	0.000382	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	4.93e-06	0.00037	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.82e-06	0.000362	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.71e-06	0.000354	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	4.64e-06	0.000349	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.34e-06	0.000326	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	4.19e-06	0.000315	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.13e-06	0.000311	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	3.82e-06	0.000287	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.64e-06	0.000273	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	3.59e-06	0.00027	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	3.56e-06	0.000268	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.35e-06	0.000252	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	3.27e-06	0.000246	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	3.27e-06	0.000246	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.8e-06	0.00021	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	2.75e-06	0.000207	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.52e-06	0.00019	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	2.51e-06	0.000189	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.16e-06	0.000162	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	2.14e-06	0.000161	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.66e-06	0.000124	CbGpPWpGaD
